Hematopoietic Neoplasm/Leukemia - Myelodysplastic Syndrome

NCT00046930

Clinical Trial Information


Trial Number: NCT00046930 (ClinicalTrials.gov)
Disease Type:
  • Hematopoietic Neoplasm/Leukemia - Acute Myeloid Leukemia
  • Hematopoietic Neoplasm/Leukemia - Myelodysplastic Syndrome
Trial Title:
A Randomized, Placebo-Controlled, Double Blind, Trial of the Administration of the MDR Modulator, Zosuquidar Trihydrochloride (LY335979), During Conventional Induction and Post-Remission Therapy in Patients Greater Than 60 Years of Age With Newly Diagnosed Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation or High-Risk Refractory Anemia With Excess Blasts
Study ID:
E3999
Images are available?:
No
Is this a NCI-MATCH Trial?:
No

NCT00843882

Clinical Trial Information


Trial Number: NCT00843882 (ClinicalTrials.gov)
Disease Type:
  • Hematopoietic Neoplasm/Leukemia - Myelodysplastic Syndrome
Trial Title:
Randomized Phase III Trial Comparing the Frequency of Major Erythroid Response (MER) to Treatment with Lenalidomide (Revlimid®) Alone and in Combination with Epoetin Alfa (Procrit®) in Subjects with Low- or Intermediate-1 Risk MDS and Symptomatic Anemia
Study ID:
E2905
Images are available?:
No
Is this a NCI-MATCH Trial?:
No

NCT00369317

Clinical Trial Information


Trial Number: NCT00369317 (ClinicalTrials.gov)
Disease Type:
  • Hematopoietic Neoplasm/Leukemia - Acute Myeloid Leukemia
  • Hematopoietic Neoplasm/Leukemia - Myelodysplastic Syndrome
Trial Title:
The Treatment of Down Syndrome Children With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Under the Age of 4 Years
Study ID:
AAML0431
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

Title Description
NCT00369317-D1 NCT00369317-D1 is the only dataset associated with this publication. The dataset contains the CONSORT flow of patient enrollment, baseline characteristics, adverse events, MRD, cytogenetics, and primary outcome analyses for patients on AAML0431 as reported in the manuscript. Also, data for patients on A2971 are provided in order to compare brief baseline characteristics and outcome to patients on AAML0431.
Subscribe to Hematopoietic Neoplasm/Leukemia - Myelodysplastic Syndrome

Accessibility  |  Disclaimer  |  FOIA  |  HHS Vulnerability Disclosure  |  Privacy & Security

U.S. Department of Health and Human Services  |  National Institutes of Health  |  National Cancer Institute  |  USA.gov

NIH…Turning Discovery Into Health®